Core Scientific, Inc. CORZ
17.34
(0.79)
(4.36%)
as of 25 Sep
- Market cap
- $5.9B
- P/E
- 0.0×
Follow CORZ
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 123.29% | 145.23% | 30.29% | 22.84% |
+8 more TTM periods Free account |
|
| (59.37%) | (46.00%) | (15.10%) | (13.19%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(145.12%) | (782.71%) | (20.51%) | (14.43%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(3.67) | (1.44) | (1.44) | (1.11) | |
Free Cash Flow |
(1,194.74) | (465.25) | (457.54) | (352.27) | |
Capital Expenditures |
(1,714.98) | (1,038.42) | (735.79) | (491.26) | |
Piotroski F-Score |
3.00 | 5.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
13.64% | 69.78% | 68.04% | 36.15% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
1.93 | 2.62 | 3.87 | 2.86 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
130.00 | 270.84 | 163.73 | 248.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
47.44% | 54.06% | 0.00% | 56.04% | |
Share Based Compensation of Revenue |
21.32% | 28.14% | 30.79% | 28.21% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.24) | (0.53) | (0.96) | (0.66) | |
Depreciation/Fixed assets |
0.05 | 0.06 | 0.07 | 0.09 | |
Capex/Depreciation |
(21.22) | (12.43) | (8.54) | (5.00) | |
Revenue per Share |
1.35 | 1.10 | 1.00 | 1.05 | |
Operating CF per Share |
1.60 | 1.78 | 0.87 | 0.44 | |
Capex per Share |
(5.27) | (3.22) | (2.31) | (1.54) | |
Capex to Sales |
3.89 | 2.93 | 2.31 | 1.47 | |
Net Profit Margin |
(487.78%) | (304.43%) | (90.47%) | (63.48%) |
Columns are period end dates